We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
Cipla (EU) Limited, UK and Pharmathen S.A. have informed the MHRA that the outer carton (box) of the product batches mentioned in this notification are missing the medicines legal classification for a Prescription Only Medicine (POM).
Employment Appeal Tribunal Judgment of Mrs Justice Eady on 18 April 2024.
UK, US and Canada regret Russia's lack of response to the Vienna Mechanism of March 2024 on prison conditions and call for immediate humanitarian release of Vladimir Kara-Murza.
Decision for applicant British Broadcasting Corporation against registration number 14988089, applicant successful.
UK and 40 other OSCE States regret Russia's lack of response to Vienna Mechanism of March 2024 on prison conditions in Russia.
Southern Region, Mr W H Gater FRICS MCIArb on 8 August 2022
Northern Region Judge J Rimmer and Member Mr J Faulkner sitting on 1 February 2024
Southern Region, Mr D Banfield FRICS on 18 April 2019
Company wound-up in the public interest after investigations by the Insolvency Service
Northern Region Judge L Bennett and Member N Walsh sitting on 6 December 2019
Decision for applicant Societe Generale against registration number 14703785, applicant successful.
A. Menarini Farmaceutica Internazionale Srl is recalling a specific batch as a precautionary measure due to the distribution of Invokana 300mg in Northern Ireland in packaging intended for the Greek market.
Southern Region, Judge D Whitney, Mr C Davies FRICS, Mr P Gammon MBE, on 4 May 2022
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Details of expired General Licences issued by OFSI.
Documents, certificates, letters and notes available at British consulates in Lebanon.
The Charity Commission has launched a statutory inquiry following concerns over how charitable funds have been used by a now sanctioned individual.
Information on variants of the SARS-CoV-2 virus.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.